Journals / Glokom Katarakt / 2006 / Cilt: 1 - Sayı: 3

Evaluation of plasma homocysteine levels in pseudoexfoliation syndrome, pseudoexfoliation glaucoma and primary open angle glaucoma

Psödoeksfoliyasyon sendromu, psödoeksfoliyasyon glokomu ve primer açık açılı glokomda plazma homosistein düzeyinin değerlendirilmesi

Pages
203–208
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies with larger series are warranted for a more precise conclusion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Our study aimed to evaluate plasma homocystein levels of patients with pseudoexfoliation syndrome(PES), pseudoexfoliation glaucoma (PEG) and primary open angle glaucoma (POAG) with that of normal subjects to find out a probable association with glaucoma.
📊
Key Findings & Data:Matherials and Methods: In our study plasma homocystein levels of 151 cases including 33 PES patients, 36 PEG patients, 42 POAG patients and 40 normal subjects labeled as control group have been determined by HPLC method .
💡
Conclusion & Impact:Further studies with larger series are warranted for a more precise conclusion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Glokom · Glokom · açık-açılı

Abstract

Purpose: Our study aimed to evaluate plasma homocystein levels of patients with pseudoexfoliation syndrome(PES), pseudoexfoliation glaucoma (PEG) and primary open angle glaucoma (POAG) with that of normal subjects to find out a probable association with glaucoma. Matherials and Methods: In our study plasma homocystein levels of 151 cases including 33 PES patients, 36 PEG patients, 42 POAG patients and 40 normal subjects labeled as control group have been determined by HPLC method . Results: No statistically significant difference was detected between the four study groups in the aspect of age and sex (p>0.05). The mean plasma homocystein levels were found to be 13.25±4.74 μmol/L in the PES group, 13.86±3.53 μmol/L in the PEG group, 13.75±3.74 μmol/L in the POAG group and 13.24±4.96 μmol/L in the control group. Statistical analysis comparing mean plasma homocystein levels and number of cases with hyperhomocysteinemia in PES, PEG and POAG groups revealed no significant difference (p>0.05). Patients in PEG and POAG groups were further classified into early, moderate and severe glaucomatous defect according to their ocular findings. Even the comparison of plasma homocystein levels between these 3 groups revealed no statistically significant difference both in PEG and POAG group (p>0.05). Conclusion: The lower plasma homocystein levels of PES and PEG groups in our study compared to similar studies in the literature lead to suspect genetic and geographical factors as responsible. Further studies with larger series are warranted for a more precise conclusion.

Özet

Amaç: Çalışmamızda psödoeksfoliasyon sendromu (PES), psödoeksfoliasyon glokomu (PEG) ve primer açık açılı glokom (PAAG) olgularında plazma homosistein düzeyinin glokomla olası bağlantısının araştırılması amaçlandı. Gereç ve Yöntem: Çalışmamızda 33’ü PES grubunda, 36’sı PEG grubunda, 42‘si PAAG grubunda olmak üzere toplam 111 olgu ile kontrol grubu olarak alınan 40 olgunun HPLC yöntemi ile plazma homosistein düzeyleri değerlendirildi. Bulgular: Çalışma kapsamındaki dört grup arasında yaş, cinsiyet açısından istatistiksel olarak anlamlı fark saptanmamıştır (p>0.05). Ortalama plazma homosistein düzeyi PES grubunda 13.25±4.74 μmol/L, PEG grubunda 13.86±3.53 μmol/L, PAAG grubunda 13.75±3.74 μmol/L ve kontrol grubunda 13.24±4.96 μmol/L olarak saptanmıştır. Ortalama plazma homosistein düzeyi ve gruplarda hiperhomosisteinemi saptanan olgu sayısı kontrol grubu ile karşılaştırıldığında istatistiksel olarak anlamlı bir farklılık bulunamamıştır (p>0.05). PEG ve PAAG grubu olgular glokomatöz hasarlarına göre erken, orta ve ileri derecede glokomatöz hasar gruplarına ayrılmış ancak bu grupların karşılaştırlmasında da üç grup arasında homosistein düzeyi açısından hem PEG ve PAAG grubunda istatistiksel olarak anlamlı bir farklılık bulunamamıştır (p>0.05). Sonuç: Literatürdeki benzer diğer çalışmalara göre çalışmamızda PES ve PEG gruplarında homosistein düzeylerinin daha düşük bulunması, coğrafik ve genetik farklılıkların sözkonusu olabileceğini düşündürmektedir. Ancak daha net bir sonuç elde etmek için geniş çalışma gruplarında yapılacak prospektif çalışmalar gereklidir.

🔖

Cite This Article

KAMIŞ, Ü., ZENGİN, N., OKKA, M., ÖZTÜRK, T. B., AKCAN, M. (2006). Evaluation of plasma homocysteine levels in pseudoexfoliation syndrome, pseudoexfoliation glaucoma and primary open angle glaucoma. Glokom Katarakt, Cilt: 1 - Sayı: 3, 203–208. https://ajindex.com/articles/226745

References (16)

  1. Kanski J: Clinical Ophthalmology 3d edition. London: Butterworth- Heinemann. 1994:233-284
  2. Clarke R, Daily L, Robinson K, et al.: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991; 324:1149-1355
  3. Vessani RM, Ritch R, Liebmann JM, et al.: Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136:41-46
  4. Libby P, Ridker PM, Genest J: The vascular biology of atherosclerosis and risk factors for atherosclerosis disease. Braunwald E, Zipes DP, Libby P. Heart Disease 6th Ed. WB Saunders Philadelphia. 2001:995-1039
  5. Hodapp E, Parrish IIRK, Anderson DR: Clinical decisions in glaucoma. St Louis, The CV Mosby. 1993;84-126
  6. Ueland PM, Refsum H, Stabler SL, et al.: Total homocysteine in plasma or serum. Method and clinical applications. Clin Chem. 1993;39:1764-1769
  7. Flammer J, Orgul S, Costa VP, et al.: The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393
  8. Stamler JS, Osborne JA, Jaraki O, et al.: Adverse vascular effects of homocysteine are modulated by endothelium- derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318
  9. Tsai JC, Perrella MA, Yoshizumi M et al.: Promotion of vascular smooth muscle cell growth by homocysteine with link atherosclerosis. Proc Natl Acad Sci USA. 1994;91:6369-6373
  10. Rodgers GM, Conn MT: Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895-901
  11. Lussier-Cacan S, Xhingnesse M, Piolat A, et al.: Plasma total homocysteine in healthy subjects: sex-spesific relation with biological traits. Am J Clin. 1996;64:687-693
  12. Perry IJ, Refsum H, Morris RW, et al.: Prospective study of serum total homocysteine concentration and risk of stroke in middleaged British men. Lancet. 1995;249:1395-1398
  13. Vine AK: Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol. 2000;129:640-644
  14. Pianka P, Almong Y, Man O, et al.: Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neurophathy central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588-1592
  15. Mitchell P, Wang JJ, Smith W: Association of pseudoexfoliation with increased vaskular risk. Am J Ophthalmol. 1997;124:685-687
  16. Brooks AMV, Gillies WE: The development of microvascular changes in the iris in pseudoexfoliation of the lens capsule. Ophthalmology. 19